Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 06:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at

Subscribe to WSJ:

Stocks mentioned in the article : Bayer AG, SANOFI
Recommend :
React to this article
Latest news on BAYER AG
1d ago Malini Moorthy Joins Bayer as U.S. Head of Litigation
2d ago BAYER : New Bayer plastic makes luggage lighter and more secure -- Travel more c..
3d ago Aurelius buys Scholl shoe business from Reckitt Benckiser
5d ago BAYER : High court's Nexavar ruling strikes a blow for patient's rights in India
6d ago BAYER : Donates to NYC Police Athletic League
7d ago BAYER : MaterialScience brings magic to materials
07/16 Ex-GSK China staff seek compensation for illegal dismissal
07/15 BAYER : MaterialScience brings magic to materials -- Global launch of INSQIN®: g..
07/14 BAYER : Donates to NYC Police Athletic League
07/10 BAYER : Presents $50,000 Science Education Grant To Honorary President Of The Po..
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
Bayer AG : Income Statement Evolution
More Financials
Dynamic quotes